Abstract In this study, differences in lipid levels amongst diabetics with and without complications were assessed to determine lipid disorders that are associated with diabetic complications other than cardiovascular diseases. A Cross sectional study design was employed. The study included 288 diabetics and 108 non diabetics with different types of complications such as hypertension, nephropathy, neuropathy, and retinopathy. The mean serum total cholesterol was higher in patients with complications compared to those without complications and the non-diabetic controls. The normotensive diabetic patients had the lowest total cholesterol among the diabetic patients' groups (4.65 ± 0.17 mmol/l) compared to the diabetics with hypertension (6.051 ± 0.20 mmol/l), retinopathy (6.26 ± 0.29 mmol/l), neuropathy (5.80 ± 0.17 mmol/l) and nephropathy patients 5.74 ± 0.26 mmol/l (P \ 0.05). The prevalence of dyslipidaemia among diabetic subjects was between 19.2 and 84.0%. The study shows that, in addition to macrovascular complications, dyslipidaemia is common in type 2 diabetes mellitus patients with microvascular complications.
Introduction
Diabetes mellitus is a heterogeneous metabolic disorder of lipid and carbohydrate metabolism. The condition is characterized by hyperglycaemia resulting from defective insulin secretion, resistance to insulin action or both [1, 2] . The prevalence reported for Ghana in the early 1990 s was 2% [3] . Subsequent studies by Amoah et al. indicate that prevalence rate rose from 0.4% in the 1950 s to 6.3% in 2000 and that type 2 accounted for 85-90% of diabetic cases in the Greater Accra region of Ghana [4] . Poor or inadequate control of persistent hyperglycaemia in diabetes mellitus leads to the development of micro and macro vascular complications often involving organ damage and finally causing death among people with diabetes mellitus [5, 6] .
Several studies show that type 2 diabetes mellitus (T2DM) is often associated with lipoprotein disorders [7] [8] [9] [10] [11] . In Ghana, a number of studies conducted on lipoprotein disorders indicate that it is associated mostly with diabetic patients who also have hypertension, a macrovascular complication, and not other microvascular complications [12] [13] [14] [15] . In Ghana, not much is known about the trends of lipoprotein disorders in type 2 diabetics with microvascular complications. Knowledge about the prevalence would draw specific attention to its management in patients with microvascular complication since the focus has been on macrovascular complications.
Methodology

Informed Consent and Ethical Approval
The Scientific and Technical Committee (STC) and Institutional Review Board (IRB) of the Noguchi Memorial Institute for Medical Research, University of Ghana, examined and approved the research proposal for this study. All participants provided written informed consent on a form approved by the STC and the IRB.
Recruitment of Participants
Sample size was calculated using 95% confidence interval, and a diabetes mellitus prevalence of 6.3% in Ghanaians. A total of 396 participants were recruited into the study comprising type 2 diabetic patients attending the Diabetes Clinic of the Tema General Hospital and healthy non-diabetic controls from the Accra-Tema metropolis of Ghana.
Inclusion Criteria
The study subjects comprised newly and previously diagnosed Ghanaian type 2 diabetes patients with fasting blood glucose (FBG) [ 6.4 mmol/l, and normal hepatic function (indicated by normal levels of AST and ALT) and with or without complications of neuropathy, retinopathy, overt nephropathy, coronary artery diseases (hypertension or stroke) and attending the diabetes clinic of the Tema General Hospital, Ghana Health Service in the Greater Accra Region of Ghana. Apparently healthy normotensive non-diabetic controls were also recruited from the same hospital.
Exclusion Criteria
Among the non diabetic control group, those with high blood pressure and also on treatment were excluded from the study to obtain normotensives. Hepatic dysfunction indicated by AST and ALT levels more than twice the upper limit of normal reference values were left out. In addition patients who had deteriorating ailment or who had been severely ill within 3 months prior to the study were also excluded from the study. Similarly patients on thyroid stimulating drugs, corticosteroids lipid-lowering drugs, oral contraceptives, aspirin and sulphonamides were excluded to avoid false elevated HDL-Cholesterol level. Pregnant women were also excluded to avoid a false overt nephropathy.
Clinical Assessment of Subjects
All participants completed a questionnaire approved for the study. Each participant, after granting his or her informed consent, was given a full physical examination by a physician. The clinical history of each patient, disease condition and treatment history as well as demographic data were also recorded. The mean of two blood pressure (BP) readings, measured on the right arm after the participants had been seated for 5 min, was recorded. Diabetes mellitus was diagnosed and classified based on the World Health Organization Criteria [16] 
Diagnosis of Diabetic Complications
Complications were diagnosed based on laboratory results and full physical examination, treatment history and examination by the study Physician. The definitions adopted in assessing coronary artery disease status and risk were hypertension, systolic BP C 140 mmHg and/or diastolic BP C 90 mmHg or participant currently receiving treatment for hypertension [18] . Risk of coronary artery diseases was based on HDL-C \ 0.75 mmol/l for males, \0.91 mmol/l for females, LDL-C [ 3.37 mmol/l for males and females and TC/HDL-C [ 4.17. For Neuropathy the definition included experience of 'pins and needles' numbness, loss of sensation, reduced ability to sense touch and vibration, bladder and bowel dysfunction, impotence, diarrhoea and change in blood pressure [19] .
Overt nephropathy (proteinuria) was defined and diagnosed based on patient repeatedly having either a urinary albumin excretion rate of [ 200 lg/min or a presence of protein in a reagent strip urinalysis tests [20] .
Retinopathy diagnosis was done based on evidence of macular oedema, blot haemorrhages, cotton wool spots, hard exudates, micro-aneurysms and other intraretinal microvascular abnormalities [21] .
Biochemical Analysis
Biochemical tests were performed on blood donated by participants after an overnight fast. Fasting blood glucose (FBG), aspartate aminotransferases (AST) and alanineaminotransferases (ALT) levels and serum lipids-triacylglycerol (TAG) total cholesterol (TC), low density lipoprotein cholesterol (LDL-C) were determined using commercial assay kits (Randox Ltd Antrium UK). The LDL-cholesterol was calculated using the Friedwald formula [22] .
Urinalysis
Early morning urine specimens were collected from all participants into clean labelled plastic containers. Urine protein was determined immediately using urine strips (URO PAPER). The results were reported according to the colour chart provided by the manufacturer.
Anthropometric Measurements
Participants were weighed in light clothing without shoes and their heights were measured with a stadiometer. Body mass index (BMI) was calculated as kilogram per metre square.
Statistical Analysis
Data was analyzed with Pearson chi-square tests for categorical variables to determine group differences. Analysis of variance (ANOVA) was also used to compare multiple means. Data analysis was performed with the statistical package SPSS version 16.0 (SPSS, Chicago, IL) and the level of statistical significance was set at P \ 0.05.
Results
General Characteristics of the Study Population
A total of 396 individuals gave their written/thumb-printed informed consent to participate in the study. The volunteers comprised 288 T2DM individuals and 108 non-diabetic normotensive individuals (Table 1 ). There were significantly more female diabetics than male diabetics and also many more normotensive non-diabetics female volunteers than males. The male diabetics were significantly older than the females (P \ 0.05). There was no statistical difference between the ages for the male and female normotensive non diabetic volunteers (P [ 0.05). Table 1 also shows that apart from the female diabetics, majority of participants have had secondary education (P \ 0.05). Furthermore, compared to the others, relatively higher male non diabetic participants have had tertiary education (P \ 0.05). Alcohol consumption was found to be relatively higher among the normotensive non-diabetic than the diabetic participants. Alcohol consumption was higher among male diabetic participants compared to female diabetics. Conversely, among the normotensive non-diabetics, more female consumed alcohol compared to males (Table 1 ). There was no smoker among the female participants. However, there were more smokers (15.22%) among the normotensive non-diabetic male participants than there were among the diabetic males (2.97%) ( Table 1 ). Both systolic and diastolic blood pressures (BP) for participants with diabetes mellitus, was significantly higher than those without diabetes (P \ 0.05). The BMI for diabetics was significantly higher among diabetics compared to non-diabetics (P \ 0.05). The female diabetics also had a significantly higher BMI than the males.
Biochemical Parameters for Non-Diabetic and Diabetics Table 2 shows that the mean TC level for diabetics was significantly higher than for non diabetics (P \ 0.05). The mean TAG level for diabetics was also significantly higher compared to non diabetics (P \ 0.05). The highest HDL-C The values for age are mean ± Standard error of mean (SEM)
Significant difference (P \ 0.05) between a male and female diabetics, b non-diabetic males and females, c female diabetics and others, d male non-diabetics and others, e diabetics and non-diabetics level was recorded for the non diabetic group. The ratio of TC to HDL-C was highest among diabetics (P \ 0.05). AST and ALT levels for both diabetics and non diabetics were not significantly different.
Lipid Levels in Diabetics with and without Complications
The results in Table 3 show that the mean total cholesterol (TC) and TAG levels for diabetics with complications were significantly higher than for those without complications (P \ 0.05). Furthermore the mean HDL-C level for diabetics with complications was significantly lower compared to those without complications (P \ 0.05). The converse was true for LDL-C levels, which was significantly higher for diabetics with complications (P \ 0.05).
The ratio of TC to HDL-C was also significantly higher among diabetics with complications (P \ 0.05). Table 4 shows that the mean TC levels for diabetics with macro-and microvascular complications were significantly higher than those without complications (P \ 0.05). The mean TAG level for diabetics with macrovascular complications was also significantly higher compared to those without complications (P \ 0.05). The participants with macrovascular complications recorded the highest LDL-C levels among the three groups. In contrast, the highest HDL-C level was recorded for diabetics without complications compared to the other two groups.
Lipid and Blood Pressure Levels of Diabetics with Micro and Macrovascular Complications
The ratio of TC to HDL-C was highest among diabetics with hypertension-a macrovascular complication (P \ 0.05). Both systolic and diastolic BP for participants with hypertension were significantly higher than those with 
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Significant difference (P \ 0.05) between a diabetics and non-diabetics, b non-diabetic males and females, c male and female diabetics Table 4 . Table 5 shows that the mean TC and LDL-C levels were relatively higher among diabetics with retinopathy compared to other complications (P [ 0.05). TC/HDL-C ratio was observed to be highest in diabetic hypertensive. HDLcholesterol was found to be relatively low in diabetic hypertensives. The blood pressure was significantly higher among hypertensives (P \ 0.05). Diabetics with nephropathy recorded a significantly lower TAG levels (P \ 0.05) compared to those with other complications. Table 6 compares the percentage frequency distribution of LDL-cholesterol, total cholesterol, triacylglycerol and HDL-cholesterol in diabetes patients using ATP (Adult Treatment Panel) III classification. Among 288 T2DM patients, 28% had neuropathy, both nephropathy and hypertension registered 17% and diabetics with retinopathy constituted 9% whereas the remaining 29% had no complications.
Distribution of Lipid Disorders in the T2DM Patients with or without Complications
In this study, using the ATP III cut-off marks, the prevalence of dyslipidaemias-(hypercholesterolemia, hypertriglyceridaemia, high LDL-cholesterol) was lower in diabetic patients without complications (19.2-26.6%), compared to those with complications (29.2-84%). Hypercholesterolemia in various complications was: 62.6% for nephropathy, 84% in retinopathy, 68.3% in neuropathy patients and 76% among those with hypertension. Hypertriglyceridaemia which was also found in all complications was highest (37.7%) in patients with diabetic neuropathy and lowest (18.8%) in those with nephropathy. The prevalence of hypertriglyceridaemia in diabetics without complications was 13.3% (Table 6 ). High LDLcholesterol disorders were recorded in the prevalence range of 62.5-80% in all complications with the least in nephropathy and the highest in retinopathy patients.
Discussion
It is well established that inadequate management and/or control of hyperglycaemia predisposes diabetic patients to a number of complications. The aim of our study was to determine the prevalence of dyslipidaemia (hypercholesterolemia, hypertriglyceridaemia and high LDL-cholesterol disorders) in diabetic patients visiting the Tema general hospital in Accra, Ghana using the revised National Cholesterol Education Program-Adult Treatment Panel (NCEP-ATP) III criteria. These criteria are used for the evaluation and treatment of lipid disorders [23] . We also investigated if any differences existed in lipid levels among diabetics with and without complications. The study showed that the major complications found in the subjects were hypertension, nephropathy, neuropathy and retinopathy. These findings are consistent with reports from other studies [12, 21, 24, 25] . The mean age of T2DM patients in this study was 55.1 ± 0.86 years and the mean duration was about 4 years. There appears to be no sex predilection for type 2 DM in this study which is similar to observations made by Fabian et al. and Vinter-Repalust et al. [25, 26] . The duration of diabetes is known to be related to the development of complications [24] . However, in this study no such association was found. The reason for this is not apparent. Meanwhile, it is reasonable to attribute it to delay in diagnoses. There was no significant difference in FBG levels between diabetics with complications and those without complications. This may be attributed to the fact that, both groups (diabetics with or without complications) were on oral hypoglycaemic agents such as daonil and metformin. The higher BMI recorded for diabetic patients in this study are consistent with previous reports [13, 15] . Dyslipidaemia is identified as a major risk factor that contributes significantly to the development of macrovascular and microvascular complications in T2DM patients. Patients with T2DM often present with adverse lipoprotein disorders [27] . In fact, hyperlipidaemia (high LDL-C, TC) is known to increase the risk for macrovascular diseases such as arterial hypertension [28] . It is believed to hasten the process of artheriosclerosis especially in the presence of hypertension and diabetes mellitus [29] since patients with hypertension and diabetes mellitus have a higher risk of developing coronary artery disease (CAD) [30] . The high TC, LDL-C, TAG levels and low HDL-C levels recorded for subjects with hypertension as a complication compared to those without complications was similar to trends reported previously [14] . Other studies have recorded lower lipid levels in Ghanaian diabetics than the levels observed in this study [15, 31, 32] . The difference could be attributed to the sampling time for the various studies since some studies have demonstrated seasonal variation in cholesterol levels [33] . The LDL-C level recorded among Ghanaians is lower than Caucasian levels [17] . The population differences have previously been observed by Nyarko et al. [15] . In this study, the high TC/HDL-C ratio in the diabetics with complications compared to those without is consistent with known trends that high TC/HDL ratio indicates risk for CAD while a low TC/HDL-C indicates a low risk for CAD [34] . Our study revealed combined hyperlipidaemia, hypercholesterolaemia and hypertriglyceridaemia among type 2 diabetics. The cause of the lipid alteration among T2DM subjects has been attributed to differential insulin distribution which leads to increased very low density lipoprotein cholesterol (VLDL-C) and triacylglycerol production through hepatic hyperinsulinaemia accompanied by decreased catabolism of triacylglycerol-rich lipoprotein as a result of relative peripheral insulin deficiency [35] Using the ATP III cut-off for hypercholesterolemia, prevalence in nephropathy, retinopathy, neuropathy, and hypertension patients are; 62.6, 84, 68.3, and 76%, respectively. Among those without any complications, 24.1% had hypercholesterolemia. Apart from the slightly higher hypertriglyceridaemia, the findings in this study compares favourably with other studies [8, 9] A low-density lipoprotein cholesterol level was reported to be normal in diabetics by Ruderman and Haudenschild [36] . This is contrary to our findings of elevated LDL cholesterol levels in Ghanaian diabetic patients in this study, especially among the patients with diabetic retinopathy and hypertension. The observation that hypertriglyceridaemia among the diabetics with complications was highest in patients with diabetic neuropathy suggests hypertriglyceridaemia induced neuropathy as postulated by Hou et al. [37] . This implies that sustained lowering of triglyceride levels could delay the progression of neuropathy, as reported by Davis et al. [38] but would be unlikely to completely reverse it.
In this study, the prevalence range of dyslipidaemia was observed to be low in diabetics without complications (19.2-26.6%) was observed but high in patients with complications (29.2-84%). The high proportion of diabetic subjects (19.2-84.0%) with lipid abnormalities in this study is similar to what Emile et al. [39] found among their T2DM patients. The dyslipidaemia seen in the T2DM patients with hypertension could be due the effects of treatment. In other studies, treatment of hypertension with b-blockers, as well as high doses of thiazide diuretics have been shown to exacerbate the dyslipidaemia in patients with hypertension and diabetes mellitus [40] .
Conclusion
The study revealed that, dyslipidaemia is common in T2DM patients in Ghana with both micro and macrovascular complications. It further reveals disorders of total cholesterol, LDL-cholesterol, HDL-cholesterol and triglyceride, in patients with complicated type 2 diabetes mellitus.
